OXURION (EBR:OXUR) | Finanzwire

PRESS RELEASE

published on 06/25/2025 at 18:00, 9 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a decrease in shareholding below the threshold. The biopharmaceutical company is focused on therapeutic innovation and clinical research technologies

Technology Clinical Research Transparency Notification Biopharmaceutical Oxurion NV
BRIEF

published on 06/19/2025 at 08:35, 9 months 6 days ago

Oxurion to Acquire Preclinical Microbiology CRO in Toulouse

Acquisition Diversification Toulouse Oxurion Microbiology CRO
PRESS RELEASE

published on 06/19/2025 at 08:30, 9 months 6 days ago

Oxurion signs a letter of intent for the planned acquisition of a preclinical microbiology CRO to diversify and strengthen its presence in the Toulouse region
Oxurion NV announces LOI to acquire 70% share capital of preclinical microbiology services company. Economic details of the transaction and growth projections disclosed

Acquisition Transaction Details Growth Projections Oxurion NV Preclinical Microbiology
BRIEF

published on 06/18/2025 at 18:05, 9 months 7 days ago

Oxurion Announces Transparency Notification from Atlas Special Opportunities II LLC

Transparency Notification Biopharmaceutical Atlas Special Opportunities Ownership Structure Oxurion
PRESS RELEASE

published on 06/18/2025 at 18:00, 9 months 7 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notification from Atlas Special Opportunities II, LLC regarding shareholding. Company combines therapeutic innovation with technology for clinical research

Clinical Research Transparency Notification Biopharmaceutical Belgium Oxurion NV
BRIEF

published on 06/12/2025 at 18:05, 9 months 13 days ago

Oxurion Reports Transparency Notification Amendments

Transparency Notification Biopharmaceutical Industry Shareholding Changes Oxurion NV Atlas Special Opportunities II
PRESS RELEASE

published on 06/12/2025 at 18:00, 9 months 13 days ago

Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications from Atlas Special Opportunities II, LLC regarding its share ownership crossing thresholds under Belgian Transparency legislation. Oxurion is a biopharmaceutical company focusing on therapeutic innovation and clinical research technologies

Clinical Research Transparency Notification Biopharmaceutical Oxurion NV Belgian Legislation
BRIEF

published on 06/12/2025 at 08:35, 9 months 13 days ago

Oxurion progresses in its acquisition of Axiodis

Acquisition Life Sciences Oxurion Axiodis FDI France
PRESS RELEASE

published on 06/12/2025 at 08:30, 9 months 13 days ago

Oxurion moves forward with the planned acquisition of Axiodis
Oxurion NV announces the lifting of a key condition precedent related to the acquisition and focuses on finalizing the transaction and strategic discussions for creating synergies with Axiodis CRO

Acquisition Biopharmaceutical Clinical Data Oxurion NV Strategic Discussions
BRIEF

published on 06/11/2025 at 18:05, 9 months 14 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Actions Transparency Biopharmaceuticals Atlas Special Opportunities Oxurion

Published on 03/25/2026 at 19:15, 4 hours 13 minutes ago

Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/25/2026 at 13:30, 9 hours 58 minutes ago

Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Published on 03/25/2026 at 13:30, 9 hours 58 minutes ago

Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification
Published on 03/25/2026 at 13:30, 9 hours 58 minutes ago

Strategic Metals Closes Project Sale
Published on 03/25/2026 at 13:25, 10 hours 3 minutes ago

Predictiv AI Expands Active Deployment of CloudRep.ai Across Healthcare, Retail, Real Estate, Travel and Global Markets

View all ACCESSWIRE

Published on 03/25/2026 at 20:00, 3 hours 28 minutes ago

Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
Published on 03/25/2026 at 19:41, 3 hours 47 minutes ago

EQS-Adhoc: STRATEC POSTS IMPAIRMENTS, REPORTS PRELIMINARY RESULTS FOR 2025, AND OFFERS GUIDANCE FOR 2026
Published on 03/25/2026 at 19:30, 3 hours 58 minutes ago

AIXTRON to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 19:26, 4 hours 2 minutes ago

EQS-Adhoc: AIXTRON SE to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 18:40, 4 hours 48 minutes ago

TULKUBASH AND KYZYLTASH MINING ASSETS: DECLARATION FROM A GROUP OF INVESTORS

View all EQS

Published on 03/25/2026 at 18:53, 4 hours 35 minutes ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 4 hours 57 minutes ago

Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 5 hours 43 minutes ago

Combined General Meeting on May 05, 2026: publication of the notice of Meeting
Published on 03/25/2026 at 17:45, 5 hours 43 minutes ago

GUILLEMOT CORPORATION: 2025 ANNUAL RESULTS
Published on 03/25/2026 at 17:42, 5 hours 46 minutes ago

2025/2026 Second quarter Sales

View all LES ECHOS COMFI WIRE

News